Petros Pharmaceuticals, Inc. (PTPI) vs China SXT Pharmaceuticals, Inc. (SXTC)
- Petros Pharmaceuticals, Inc. PTPI 0.00 NaN
- China SXT Pharmaceuticals, Inc. SXTC 2.92 −0.34%
Petros Pharmaceuticals, Inc. and China SXT Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. China SXT Pharmaceuticals, Inc. is the larger, with a market value of $2.0M against $1.0M — 1.9× the size. Petros Pharmaceuticals, Inc. grew revenue faster over the last twelve months: −12.2% against −54.0%. Petros Pharmaceuticals, Inc. has the higher net margin (0.00% vs −255.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Petros Pharmaceuticals, Inc. leads on 8 and China SXT Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | PTPI | SXTC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 118.32% | 36.69% | 53.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | (255.16%) | (2.45%) |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (710.28%) | 0.00% | (0.80%) |
| Return on assets | (334.15%) | 0.00% | (1.67%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack